“We’re excited about the formation of the new Septodont Foundation. It marks the beginning of a new chapter for our Group’s philanthropic activities and will help us continue to deliver on our commitment to giving back to the world in which we live and work”, says Olivier Schiller, CEO of the Septodont Group.
We are very happy and proud to share that Biodentine counts now over 500 publications (source Pubmed), supporting the major benefits the product brings in restorative, endodontic and pediatric procedures. Another opportunity for us to thank the scientific community for endorsing Biodentine and such innovations that make dentistry always better.
Discover five clinical cases reported by dental professionals around the world who share their experience and the benefits of using Septodont innovations in their daily practice. Special focus on RTR and Biodentine™.